Diagnostic Value of Fiberoptic Bronchoscopy in Non-resolving Pneumonia: Case Series and Implications
Abstract
Non-resolving or slowly resolving pneumonia presents a significant diagnostic challenge, characterized by persistent radiographic abnormalities despite appropriate antibiotic therapy. This study explores the pivotal role of Fiberoptic Bronchoscopy (FOB) in diagnosing and managing non-resolving pneumonia. Through detailed case presentations, the study illustrates how FOB facilitates precise sampling and identification of underlying causes such as malignancies, infections, and other pulmonary conditions. FOB's ability to provide cytological, microbiological, and pathological insights proves essential in guiding targeted treatment strategies, ultimately improving patient outcomes. The cases discussed underscore the importance of FOB in resolving diagnostic uncertainties, particularly in complex clinical scenarios where standard treatments fail.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.